The effect of food composition on serum testosterone levels after oral administration of Andriol® Testocaps®
Authors: Schnabel, Peter G.1; Bagchus, Wilma; Lass, Holger2; Thomsen, Torben3; Geurts, T. B. Paul4
Source: Clinical Endocrinology, Volume 66, Number 4, April 2007 , pp. 579-585(7)
Publisher: Blackwell Publishing
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Summary Objective Andriol® Testocaps® is a new oral formulation of testosterone undecanoate (TU) for treatment of hypogonadism. As TU is taken up by the intestinal lymphatic system, both the presence and the composition of food influence the absorption. The aim of this study was to investigate the effect of food composition on the pharmacokinetics of oral TU. Design An open-label, single-centre, four-way crossover study. With a washout period of 6-7 days, 80 mg TU was administered in the morning 5 min after consuming each of four different meals in a randomized order (A: 230 kcal, 0·6 g lipid; B: 220 kcal, 5 g lipid; C: 474 kcal, 19 g lipid; D: 837 kcal, 44 g lipid). Patients Twenty-four postmenopausal volunteers. Measurements Serial blood samples were collected until 24 h after dosing to determine testosterone and dihydrotestosterone (DHT) by gas chromatography-mass spectroscopy (GC-MS). Results The bioavailability of testosterone after a low-calorie meal containing 0·6 g lipid or 5 g lipid was relatively low, the area under the concentration-time curve (AUC0-tlast) for testosterone being 30·7 and 43·5 nmol h/l, respectively. The bioavailability of testosterone after a meal containing 19 g lipid was considerably higher (AUC0-tlast = 146 nmol h/l), whereas increasing the lipid content to 44 g lipid did not further increase the bioavailability of testosterone (AUC0-tlast = 154 nmol h/l). Conclusion Approximately 19 g of lipid per meal efficiently increases absorption of testosterone from oral TU. Therefore, coadministration with a normal rather than a fatty meal is sufficient to increase serum testosterone levels when using oral TU.Document Type: Research article
DOI: 10.1111/j.1365-2265.2007.02781.x
Affiliations: 1: Department of Clinical Pharmacology and Kinetics, NV Organon, Oss, the Netherlands, 2: Department of Bioanalytics, Organon Development GmbH, Waltrop, Germany, 3: Pharm PlanNet Contract Research GmbH, Mönchengladbach, Germany, and 4: International Medical Services, NV Organon, Oss, the Netherlands
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Click here for Page Help